Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) stock fell -3.08% on Wednesday to $185.92 against a previous-day closing price of $191.83. With 0.55 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.79 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $192.07 whereas the lowest price it dropped to was $185.63. The 52-week range on ALNY shows that it touched its highest point at $242.97 and its lowest point at $120.43 during that stretch. It currently has a 1-year price target of $250.54. Beta for the stock currently stands at 0.48.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ALNY was down-trending over the past week, with a drop of -3.78%, but this was down by -8.03% over a month. Three-month performance dropped to -5.26% while six-month performance fell -10.03%. The stock gained 43.48% in the past year, while it has lost -21.77% so far this year. A look at the trailing 12-month EPS for ALNY yields -8.70 with Next year EPS estimates of -2.56. For the next quarter, that number is -1.53. This implies an EPS growth rate of -29.10% for this year and 58.30% for next year.
Float and Shares Shorts:
At present, 124.11 million ALNY shares are outstanding with a float of 122.39 million shares on hand for trading. On Apr 27, 2023, short shares totaled 5.08 million, which was 4.08% higher than short shares on Mar 30, 2023. In addition to Dr. Yvonne L. Greenstreet M.B.A., MBA, MBChB as the firm’s CEO & Director, Dr. Akshay K. Vaishnaw M.D., Ph.D. serves as its Pres.
Through their ownership of 98.85% of ALNY’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 70.75% of ALNY, in contrast to 26.57% held by mutual funds. Shares owned by individuals account for 17.92%. As the largest shareholder in ALNY with 13.27% of the stake, Capital Research & Management Co holds 16,476,201 shares worth 16,476,201. A second-largest stockholder of ALNY, Fidelity Management & Research Co, holds 12,806,585 shares, controlling over 10.32% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in ALNY, holding 11,326,916 shares or 9.13% stake. With a 6.11% stake in ALNY, the American Funds Growth Fund of Ame is the largest stakeholder. A total of 7,586,953 shares are owned by the mutual fund manager. The Vanguard Health Care Fund, which owns about 3.80% of ALNY stock, is the second-largest Mutual Fund holder. It holds 4,718,518 shares valued at 939.93 million. Vanguard Total Stock Market ETF holds 3.11% of the stake in ALNY, owning 3,859,875 shares worth 768.89 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, ALNY reported revenue of $224.82M and operating income of -$191.69M. The EBITDA in the recently reported quarter was -$168.50M and diluted EPS was -$2.29.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ALNY since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With ALNY analysts setting a high price target of $415.00 and a low target of $136.00, the average target price over the next 12 months is $251.27. Based on these targets, ALNY could surge 123.21% to reach the target high and fall by -26.85% to reach the target low. Reaching the average price target will result in a growth of 35.15% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded ALNY stock several times over the past three months with 7 Buys and 33 Sells. In these transactions, 38,112 shares were bought while 38,326 shares were sold. The number of buy transactions has increased to 35 while that of sell transactions has risen to 87 over the past year. The total number of shares bought during that period was 193,697 while 169,895 shares were sold.